Petróleo Brasileiro SA vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Petróleo Brasileiro SA trades at $24.69 (market cap $149.03B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Petróleo Brasileiro SA is far larger — about 65.4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Petróleo Brasileiro SA pays a 6.98% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| PBR | SLS | |
|---|---|---|
Market Cap | $149.03B | $2.28B |
Volume | 30,322,411 | 3,128,960 |
Sector | Energy | Health |
52-Week High | $24.69 | $15.46 |
52-Week Low | $11.54 | $1.39 |
Typical Hold Time | 25 Days | — |
Enterprise Value | $209.45B | $2.15B |
Dividend Yield | 6.98% | — |
Signals from Pluang's Aura AI — not financial advice
Petrobras (PBR) trades at $23.99, up 0.8% with strong bullish technical signals from moving averages. The company shows robust fundamentals with a P/E of 6.06, net income margin of 24.52%, and ROE of 30.77%. Recent Q2 2026 earnings beat expectations at $1.62 EPS versus $1.52 expected. Positive developments include new oil discoveries and platform deployments boosting production capacity.
PBR presents compelling value with attractive valuation metrics and strong profitability, though current price sits near analyst consensus target of $22.33. Key risks include political interference in Brazil and capital expenditure pressures. The stock offers dividend yield potential with recent $0.53 dividend declaration, supported by 50% analyst buy ratings.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.
Read more on PBR →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →